3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
31
Colorectal Neoplasms
18
Carcinoma, Hepatocellular
18
Stomach Neoplasms
12
Esophageal Squamous Cell Carcinoma
12
Squamous Cell Carcinoma of Head and Neck
9
Neoplasm Metastasis
9
Advanced Solid Tumor
9
Lung Neoplasms
7
Head and Neck Neoplasms
7
Rectal Neoplasms
5
Esophageal Neoplasms
5
Small Cell Lung Carcinoma
4
Neoplasms
4
Nasopharyngeal Carcinoma
4
Melanoma
4
Solid Tumor
3
Lymphoma, Follicular
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Biliary Tract Neoplasms
3
Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma
2
Hodgkin Disease
2
Interventions
Cyclophosphamide
7
Etoposide
5
Prednisone
4
Doxorubicin
4
Vincristine
3
romidepsin
2
pembrolizumab
2
etoposide phosphate
2
duvelisib
2
Melphalan
2
Brentuximab Vedotin
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
sodium-iodide symporter
1
ruxolitinib
1
prednylidene
1
glofitamab
1
fludarabine phosphate
1
fludarabine
1
deltacortene
1
cemiplimab
1
brincidofovir
1
belinostat
1
X-Rays
1
Whole-Body Irradiation
1
Valganciclovir
1
Therapeutics
1
Tacrolimus
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
tislelizumab
×
1 year
×
Clear all
No trials found.